# Phase 1 clinical trial

> The first stage of human testing for a new drug, focused on safety, tolerability, dosing and how the body processes it, usually in a small group.

Source: https://www.quantisnow.com/glossary/phase-1-trial
Topic: Glossary / Biotech and FDA
Also known as: Phase 1 trial, Phase I trial, first-in-human trial, Phase 1 study
Last updated: 2026-10-27

A Phase 1 clinical trial is the first stage of testing an investigational drug in humans. Its main goals are to assess safety and tolerability, find a safe dose range, and measure pharmacokinetics (how the body absorbs, distributes, metabolizes and clears the drug).

## How it works

Phase 1 begins once an [IND](https://www.quantisnow.com/glossary/ind) is in effect. Studies typically enroll about 20 to 100 participants. For most drugs these are healthy volunteers, but in oncology and some severe diseases the trials enroll patients, since the drugs may be too toxic for healthy people.

Common designs include:

- **Single ascending dose (SAD):** small groups receive one dose, with each group getting a higher dose than the last if safety allows.
- **Multiple ascending dose (MAD):** the same approach with repeated dosing.
- **Dose escalation in patients** to find the maximum tolerated dose or recommended Phase 2 dose.

Some programs run combined Phase 1/2 trials that add expansion cohorts to look for early efficacy.

## Why it matters for traders

Phase 1 data are mostly about safety, so the bar for a positive readout is "no unexpected problems". Exceptions draw big moves: patient-enrolling oncology and rare-disease trials can show early efficacy signals such as tumor responses or biomarker changes, and those can rerate a small-cap biotech. Serious adverse events or a clinical hold can do the opposite. Small sample sizes mean early efficacy numbers can shift substantially as more patients are dosed.

## Example

Northwind Therapeutics (NWTX) runs a dose-escalation Phase 1 in 24 patients with an advanced solid tumor, enrolled in cohorts of three to six. At the two highest doses, 4 of 12 patients show tumor shrinkage, a 33% response rate. The company selects a recommended Phase 2 dose and the stock rallies on the early signal.

## FAQ

### What is the main purpose of a Phase 1 trial?

To establish safety and dosing. Efficacy is usually not the primary goal.

### Are Phase 1 trial participants healthy?

Often, but not always. Cancer and some rare disease trials enroll patients from the start.

## Related terms

- [Investigational New Drug application (IND)](https://www.quantisnow.com/glossary/ind.md): The FDA filing a sponsor must have in effect before testing an unapproved drug or biologic in humans in the United States.
- [Phase 2 clinical trial](https://www.quantisnow.com/glossary/phase-2-trial.md): The mid-stage of drug testing in patients, designed to show early evidence that a drug works, refine the dose and further assess safety.
- [Phase 3 clinical trial](https://www.quantisnow.com/glossary/phase-3-trial.md): The large, late-stage trial that tests whether a drug works and is safe in a broad patient population, usually forming the basis for an FDA application.
- [Topline data](https://www.quantisnow.com/glossary/topline-data.md): The first high-level results from a clinical trial, usually covering the primary endpoint and key safety findings, released before the full dataset.
- [Primary endpoint](https://www.quantisnow.com/glossary/primary-endpoint.md): The main outcome a clinical trial is designed and statistically powered to measure, used to judge whether the drug worked.

## On Quantisnow

- [Clinical trial phases explained](https://www.quantisnow.com/guides/clinical-trial-phases)
- [Live feed: FDA Approvals](https://www.quantisnow.com/news/fda)
- [FDA approval process](https://www.quantisnow.com/guides/fda-approval-process)
- [Latest clinical trial results](https://www.quantisnow.com/top/clinical-trial-results)
